News

Sheba Has Been Designated an Official Micra Pacemaker Training Center
A pacemaker, also called a cardiac pacing device, is a small apparatus that’s placed (implanted) in the chest to help control the heartbeat by sending electrical pulses. It keeps the heart beating regularly and prevents it from beating too slowly. However, pacemaker implantation involves a complicated surgical procedure. In 2006, Medtronic made history by being […]
Read More

New Hope for Peritoneal Cancer Patients
Peritoneal cancer is a rare malignancy that develops in the peritoneum, a membrane that lines the walls of the abdominal cavity and rests on the abdominal and pelvic organs. Whether originating from a primary tumor within the peritoneum or a metastatic tumor elsewhere in the body, peritoneal cancer is a terminal disease with a poor […]
Read More

Three Tips for Better Health From Sheba’s Experts
The first step to taking control of your eating habits is simple: prepare your own food. Cooking at home not only gives you the ability to know exactly what goes into your meal, but also has a multitude of additional benefits. The act of cooking requires skills that many people do not regularly utilize, bringing […]
Read More

Zantrene May Promote Long-term Remission in Acute Myeloid Leukemia Patients, Sheba Study Indicates
Zantrene, also known by its generic name bisantrene dihydrochloride, is an anti-cancer drug used both as a low-dose targeted precision oncology agent as well as a cardio-protective chemotherapy drug. Zantrene was developed by Australian Race Oncology, who, together with Sheba, launched a clinical trial for the treatment of relapsed or refractory acute myeloid leukemia (AML) […]
Read More

Maria’s Story of Adversity and Hope
After developing a fever, 4-year-old Maria was brought to the hospital in her native Cyprus by her parents, Nikolas and Ioana. Doctors diagnosed her with pneumonia, but after only a few days her condition rapidly deteriorated and they feared for her life. It became clear that Maria’s survival was dependent on access to an ECMO […]
Read More

Study of Human Lymphocyte Antigen Peptides Reveals New Possible Lung Cancer Treatments
Headed by Dr. Michael Peled, researcher and attending physician at Sheba’s Institute for Pulmonary Medicine, and Prof. Arie Admon of the Technion – Israel Institute of Technology, the study involved isolating and analyzing peptides (a short chain of amino acids) found in lung fluid, proving that human lymphocyte (a type of white blood cell) antigen […]
Read More

Oral Immunotherapy Decreases Allergic Reaction to Peanuts in Children, Sheba Study Finds
The seminal study, published in the Annals of Allergy, Asthma & Immunology, was conducted over the course of two years at Sheba Medical Center and analyzed data from children ranging in age from 1 to 18 years with diagnosed peanut allergies. The study indicates that fixed-dose oral immunotherapy safely reduces sensitivity in children with high-threshold […]
Read More

Sheba and Toronto General Explore Lung Transplantation Advances in a Joint Conference
Clinicians from Toronto General Hospital joined Sheba’s experts at the second scientific conference arranged by Sheba’s Lung Transplant Program to explore advanced lung preservation and sterilization techniques before transplant. One of the most significant breakthroughs discussed was a new research demonstrating techniques to preserve lungs outside the donor’s body for up to 72 hours. Procedures […]
Read More

From Harrowing Beginnings to a Happy Conclusion: Aknur’s Journey to Recovery
“Aknur was born prematurely when I was only 28 weeks pregnant,” recalled her mother, Diana. “As her lungs were not yet able to function on their own, she was on ventilation during her first two months, three weeks of which she spent in the NICU. Shortly after we were finally discharged, Aknur was diagnosed with […]
Read More